Latest & greatest articles for influenza

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on influenza or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on influenza and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for influenza

81. Influenza vaccines in immunosuppressed adults with cancer. Full Text available with Trip Pro

Influenza vaccines in immunosuppressed adults with cancer. This is an update of the Cochrane review published in 2013, Issue 10.Immunosuppressed cancer patients are at increased risk of serious influenza-related complications. Guidelines, therefore, recommend influenza vaccination for these patients. However, data on vaccine effectiveness in this population are lacking, and the value of vaccination in this population remains unclear.To assess the effectiveness of influenza vaccine (...) in immunosuppressed adults with malignancies. The primary review outcome is all-cause mortality, preferably at the end of the influenza season. Influenza-like illness (ILI, a clinical definition), confirmed influenza, pneumonia, any hospitalisations, influenza-related mortality and immunogenicity were defined as secondary outcomes.We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase and LILACS databases up to May 2017. We searched the following conference proceedings: ICAAC

2018 Cochrane

82. The Cost of Interventions to Increase Influenza Vaccination: A Systematic Review Full Text available with Trip Pro

The Cost of Interventions to Increase Influenza Vaccination: A Systematic Review Influenza vaccination rates remain below Healthy People 2020 goals. This project sought to systematically review economic evaluations of healthcare-based quality improvement interventions for improving influenza vaccination uptake among general populations and healthcare workers.The databases MEDLINE, Econlit, Centre for Reviews & Dissemination, Greylit, and Worldcat were searched in July 2016 for papers published (...) from January 2004 to July 2016. Eligible studies evaluated efforts by bodies within the healthcare system to encourage influenza vaccination by means of an organizational or structural change. For each study, program costs per enrollee and per additional enrollee vaccinated were derived (excluding vaccine costs, standardized to 2017 U.S. dollars). Complete economic evaluations were examined when available.Of 2,350 records, 18 articles were eligible and described 29 unique interventions. Most

2018 EvidenceUpdates

83. Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection. Full Text available with Trip Pro

Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection. Acute myocardial infarction can be triggered by acute respiratory infections. Previous studies have suggested an association between influenza and acute myocardial infarction, but those studies used nonspecific measures of influenza infection or study designs that were susceptible to bias. We evaluated the association between laboratory-confirmed influenza infection and acute myocardial infarction.We used the self (...) -controlled case-series design to evaluate the association between laboratory-confirmed influenza infection and hospitalization for acute myocardial infarction. We used various high-specificity laboratory methods to confirm influenza infection in respiratory specimens, and we ascertained hospitalization for acute myocardial infarction from administrative data. We defined the "risk interval" as the first 7 days after respiratory specimen collection and the "control interval" as 1 year before and 1 year

2018 NEJM

84. The immunogenicity and safety of oil-in-water adjuvanted influenza vaccines: a systematic review and meta-analysis of randomised controlled trials

The immunogenicity and safety of oil-in-water adjuvanted influenza vaccines: a systematic review and meta-analysis of randomised controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2018 PROSPERO

85. Is there a difference in the immune response, efficacy, effectiveness, and safety of seasonal influenza vaccine in men and women? A systematic review

Is there a difference in the immune response, efficacy, effectiveness, and safety of seasonal influenza vaccine in men and women? A systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2018 PROSPERO

86. A systematic review of the effectiveness of maternal influenza vaccination in preventing maternal and infant influenza

A systematic review of the effectiveness of maternal influenza vaccination in preventing maternal and infant influenza Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2018 PROSPERO

87. Oil-in-water emulsion adjuvant for pediatric influenza vaccines: a systematic review and meta-analysis

Oil-in-water emulsion adjuvant for pediatric influenza vaccines: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2018 PROSPERO

88. Seasonal influenza vaccination during pregnancy: an update of systematic review of effectiveness and adverse effects

Seasonal influenza vaccination during pregnancy: an update of systematic review of effectiveness and adverse effects Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2018 PROSPERO

89. Laninamivir for treatment and prophylaxis of influenza in adults and children: a systematic review and meta-analysis

Laninamivir for treatment and prophylaxis of influenza in adults and children: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2018 PROSPERO

90. The influence of health systems on childhood immunisation and influenza vaccination: an umbrella review of European reports and reviews

The influence of health systems on childhood immunisation and influenza vaccination: an umbrella review of European reports and reviews Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2018 PROSPERO

91. Global disease burden estimates of acute lower respiratory infections due to seasonal influenza in young children in 2015: a systematic review and meta-analysis

Global disease burden estimates of acute lower respiratory infections due to seasonal influenza in young children in 2015: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr

2018 PROSPERO

92. Efficacy and safety of different vaccines to prevent seasonal influenza: a systematic review

Efficacy and safety of different vaccines to prevent seasonal influenza: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2018 PROSPERO

93. Social and psychological determinants of seasonal influenza vaccination uptake in policy recommended groups: an umbrella review

Social and psychological determinants of seasonal influenza vaccination uptake in policy recommended groups: an umbrella review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2018 PROSPERO

94. The effect of smoking on the risk of developing influenza in adults: a systematic review and meta-analysis

The effect of smoking on the risk of developing influenza in adults: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation

2018 PROSPERO

95. Cost- effectiveness of seasonal influenza vaccination during pregnancy: a systematic review

Cost- effectiveness of seasonal influenza vaccination during pregnancy: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2018 PROSPERO

96. The association between socioeconomic factors and pandemic influenza: protocol for a systematic review and meta-analysis

The association between socioeconomic factors and pandemic influenza: protocol for a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2018 PROSPERO

97. The effectiveness of influenza vaccine in reducing influenza-associated mortality in children under five years old: a systematic review protocol

The effectiveness of influenza vaccine in reducing influenza-associated mortality in children under five years old: a systematic review protocol Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2018 PROSPERO

98. Updated and new systematic reviews of non-randomized studies for the World Health Organization guideline for the (pharmacological) management of severe influenza (including seasonal, pandemic and zoonotic influenza)

Updated and new systematic reviews of non-randomized studies for the World Health Organization guideline for the (pharmacological) management of severe influenza (including seasonal, pandemic and zoonotic influenza) Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated

2018 PROSPERO

99. Predictors of uptake and adherence to seasonal influenza vaccination among 65 years or older adults: a systematic review

Predictors of uptake and adherence to seasonal influenza vaccination among 65 years or older adults: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2018 PROSPERO

100. Early risk assessment: What to expect of the 2017/18 influenza season in Norway

Early risk assessment: What to expect of the 2017/18 influenza season in Norway What to expect of the 2017/18 influenza season in Norway - NIPH Selected items added to basket Close Search for: Søk Meny Infectious diseases & Vaccines Close Mental & Physical health Close Environment & Lifestyle Close Health in Norway Close Quality & Knowledge Close Research & Access to data Close About NIPH Close What to expect of the 2017/18 influenza season in Norway Have you found an error? Order Download (...) : Summary The report is based on data from a late-summer serosurvey, early-season surveillance data, vaccine sales and experience from previous influenza seasons. The report is meant to support capacity planning in the health services, provide background information to infection control and other health-care and public health personnel, as well as to provide in-depth information on influenza outbreaks in general. At this point, as the 2017-2018 outbreak is beginning to unfold, it is of particular

2018 Norwegian Institute of Public Health